Synapsoft logo
AI Insights from Disclosures
Searching...
BNC KOREA, Inc. 256840
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
BNC KOREA, Inc. and its consolidated subsidiaries have, since their establishment in 2007, engaged in the research and development of strategic application products set to lead the next-generation bio market, such as medical devices, anti-aging beauty devices, pharmaceuticals, and cosmeceutical products, by processing biomaterials such as hyaluronic acid and collagen, as well as the distribution of diagnostic reagents and testing equipment. The company's main products include HA fillers using hyaluronic acid, biopharmaceuticals using botulinum toxin, anti-adhesion materials, and collagen-absorbable wound dressings using collagen, all of which are classified as medical devices.
Representative Director Choi Wangyu
Founded October 14, 2016
Corporation Type KOSDAQ
Industry Classification Manufacture of medicinal chemicals
Corporate number 11011-6202305
Business number 404-86-00676
Phone Number 070-7116-0059
Fax Number 053-592-0152
Company Address 62 Seongseogongdan-ro 11-gil, Dalseo-gu, Daegu
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant